Despite their transient immune engagement and incomplete TME restoration, PDX-based humanized models infused with autologous PBMCs remain the most physiologically relevant system for studying tumor–immune interactions in trastuzumab-resistant HER2-positive cancers. This evidence concerns the gene ERBB2 and cancer.